Health ❯ Clinical Trials

Drug Development

Regulatory Approval Phase 3 Trials Cancer Treatments Regulatory Affairs Oncology Eli Lilly Combination Therapy FDA Approval Pre-clinical Studies Safety Testing Weight Loss Neurological Disorders Pharmacokinetics Antiviral Therapies Pilot Studies Phase 1 Trials Pipeline Programs Patient Outcomes Phase I Trials Amivantamab Alzheimer's Treatments CagriSema Therapeutic Uses Patient-Derived Organoids Preclinical Testing Manufacturing Facilities Cancer Drugs GLP-1 Drugs Male Birth Control Combination Therapies HypoxyStat Biomarkers Asthma Medications SARM1 Therapeutics Regulatory Approvals Repurposing Drugs Efficacy Studies India Rare Diseases Novo Nordisk Male Contraceptive Trials PMX205 Hormonal Research Preclinical Models Semaglutide Phase 2 Trials Neuropharmacology Human Health Safety Trials Research Institutions Inhibitors Hematology IRE1α Inhibitors Therapeutic Evaluation Precision Medicine

Gilead to Acquire Arcellx for Up to $7.8 Billion to Gain Full Control of CAR-T Anito-Cel

The purchase secures full control of anito-cel, a BCMA-directed cell therapy under FDA review with a December 23 action date.

p‑Tau217 Blood Tests Boost Alzheimer’s Diagnosis and Predict Onset Within a Few Years

Hypoxia Turns Red Blood Cells Into Glucose Sinks, Pointing to New Diabetes Therapies

Low-Dose THC Paired With Celecoxib Improves Cognition and Alzheimer’s Pathology in Mice

Novo Nordisk Files for 7.2 mg Wegovy Dose After Stronger Weight-Loss Results

Immune Cell Stress Switch Implicated in Chemo Neuropathy, With Existing Inhibitors Poised for Tests

Merck’s Oral PCSK9 Pill Matches Injectables in Phase 3, Setting Up 2026 FDA Bid

Blocking C5aR1 Preserves Memory in Mouse Brain Radiotherapy Without Undermining Tumor Control

NRG Therapeutics Raises £50M to Advance Mitochondrial Neurodegeneration Drug Into the Clinic

Kidney Organoids Reveal NFκB‑Linked AAV2 Toxicity, With Bardoxolone Methyl Mitigating Damage

Adaptimmune Sells Tecelra and Late-Stage Cell Therapies to U.S. WorldMeds for $55M

Leukemia-on-a-Chip Enables Rapid, Scalable CAR T-Cell Therapy Screening

Novo Nordisk’s Amycretin Achieves Up to 24% Weight Loss as It Advances to Phase 3

Silencing Enzyme Gene Boosts NK Cell Cancer-Fighting Power

Cancer drug pair extends mouse lifespan by 30% as researchers plan human trials